Use of MAPK pathway inhibitors for the treatment of Friedreich Ataxia . University of Pennsylvania, posted on 05/19/2015
Brief Description: A novel treatment for rare disease Friedreich ataxia using p38 or MK2 kinase inhibitors
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.